Trial intelligence / Profile preview

Fluid replacement with colloids and its impact on platelets, hemostasis and renal function

DRKS00004452Phase 3Active, not recruiting

Sponsor
Medical University of Vienna
Start
Oct 2012
Modality
Recombinant Proteins and Enzymes, Small Molecules
Countries
1
01

Overview

Phase 3 trial of albumin (human), hetastarch and succinylated gelatin in hypovolemia, Shock, dehydration and 1 more (3 arms), sponsored by Medical University of Vienna. Started Oct 2012; status: active, not recruiting.

02

Drugs

albumin (human)hetastarchsuccinylated gelatin
03

Conditions

hypovolemiaShockdehydrationTraumatic shock

Beyond the preview

Go deeper on DRKS00004452.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on DRKS00004452.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call